Sima Sharara

ID Fellow/Bug Fighter in Training at @JHMed_ID
@OslerResidency ‘23 | @AUBMC_official '18

[Sima Sharara @simasharara]

Couldn’t be more excited to start this adventure with such an amazing group! 💫 #OslerPride

[Sanjay Desai @sanjayvdesai]

#OslerPride

[Christle Nwora, MD @ChristleNwora]

First of what I’ll imagine will be many zoom calls and hangouts with my Longcope intern fam!

[Rana Sharara MD @RanaSharara]

Lebanon's coronavirus outbreak is surprising - The Washington Post #COVID19 https://t.co/phGC1P9tZH

[Johns Hopkins Hospital Antimicrobial Stewardship @JHH_ASP]

A must read to use blood cultures wisely ⁦@sanjayvdesai⁩ ⁦@OslerResidency⁩ ⁦@ssharara2⁩ ⁦@ValeriaFabreMD⁩

[Steffanie Strathdee, PhD 🗡️ 🦠Superbug Slayer🗡️ @chngin_the_wrld]

Today's #shoutout to #womenInSTEM goes to @ssharara2 for her CID paper assessing whether Piperacillin-Tazobactam is effective for treatment of #ESBL-associated #Pyelonephritis. #AMR #superbugs #antibioticresistance https://t.co/7OpQLYvrB5

[Sima Sharara @simasharara]

Excited to share our new article that describes a framework for identifying post-access breast tissue expander infection and provides infection prevention guidelines for safer BTE access #infectionprevention #infectioncontrol #ICHE @ValeriaFabreMD @ClareRock1

[Infection Control & Hospital Epidemiology @ICHEJournal]

There are no surveillance criteria for SSI after breast tissue expander access. This report in ICHE from @ssharara2 & colleagues provides a framework to define post-access BTE infection & infection prevention guidelines for access. #infectionprevention
https://t.co/dsNNlEDeiE